ZENG LING (Chief Legal Officer & Sec'y) sold 29.3% of their position (1.33K shares) of DICERNA PHARMACEUTICALS INC on the open market
Open‑market sale worth $28.6K — a significant reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 9/17/2021ACC: 0001399529-21-000150
Officer· Chief Legal Officer & Sec'y
Since Sep 2020
-1.33K
Net shares
Net seller
$28.6K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
4.56K acquired · 5.89K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+4.56K
Price / share
—
Trade value
—
% of position
New position
9/15/2021
0.00→4.56K
Common Stock
Direct
Shares
−1.33K
Price / share
$21.47
Trade value
$28.64K
% of position
29.3%
9/17/2021
4.56K→3.22K
Total
Net shares
+3.22K
Net value
-$28.64K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 9/15/2021 | M · Option Exercise | +4.56K | — | — | New position | 0.00 | 4.56K |
| Common Stock Direct | 9/17/2021 | S · Sale | −1.33K | $21.47 | $28.64K | 29.3% | 4.56K | 3.22K |
| Total | +3.22K | -$28.64K | ||||||
Derivative Transactions1
Restricted Stock Units
Direct
Converts to
Common Stock
4.56K shares
Shares
−4.56K
Strike price
Held after
13.67K
Exercisable
—
9/15/2021
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Restricted Stock Units Direct | Common Stock4.56K shares | 9/15/2021 | M · Option Exercise | −4.56K | — | 13.67K |